- TMPRSS2: A potential target for treatment of influenza virus and coronavirus infections
- Bromhexine Hydrochloride: Potential Approach to Prevent or Treat Early Stage Novel 2019 Coronavirus Disease
- Repurposing the mucolytic cough suppressant and TMPRSS2 protease inhibitor bromhexine for the prevention and management of SARS-CoV-2 infection
- Ambroxol Hydrochloride Inhibits the Interaction between Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein’s Receptor Binding Domain and Recombinant Human ACE2
- Potential new treatment strategies for COVID-19: is there a role for bromhexine as add-on therapy?
- TMPRSS2 inhibitors, Bromhexine, Aprotinin, Camostat and Nafamostat as potential treatments for COVID-19.
- Effect of bromhexine on clinical outcomes and mortality in COVID-19 patients: A randomized clinical trial
More such studies are referenced in Hustenmittel Bromhexin als wirksames Medikament gegen Covid-19.
Leave a Reply